Company / Working Capital per Share
Celldex Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$7.27
FY2025
5-year range
$6.34 / $10.66
FY2021-FY2025
Trend
-31.8%
vs FY2024
Sector context
#59 of 159
Health Care
What the data says
At $7.27, Celldex Therapeutics, Inc.'s working capital per share ranks #59 of 159 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.97 in FY2017 to $10.66 in FY2024.
Based on SEC 10-K filings.
7.27 in FY2025 with a 5-year CAGR of +9.4%.
Remained stable around $7.27 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
#59 of 159 in Health CareTop 37% of 159This company $7.27 Sector average $24.27
▼
-70.0% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 31.8% year-over-year.
- Ranks #59 out of 159 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2024.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.27 | -31.8% |
| FY2024 | $10.66 | +48.7% |
| FY2023 | $7.17 | +13.1% |
| FY2022 | $6.34 | -24.9% |
| FY2021 | $8.44 | +82.0% |
| FY2020 | $4.64 | +42.9% |
| FY2019 | $3.24 | -65.4% |
| FY2018 | $9.36 | +864.4% |
| FY2017 | $0.97 | -27.0% |
| FY2016 | $1.33 | -50.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026